Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation

Molecular Biology of the Cell

Volumn 17, Issue 11, 2006, Pages 4888-4895

  Okahara, Fumiaki ^a,b,f   Itoh, Kouichi ^c   Nakagawara, Akira ^d   Murakami, Makoto ^a,e   Kanaho, Yasunori ^b   Maehama, Tomohiko ^a,f  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^d CHIBA CANCER CENTER   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION 2 PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN INTERACTING WITH THE CARBOXY TERMINUS 1; PROTEIN KINASE B; REGULATOR PROTEIN; STAUROSPORINE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DEPHOSPHORYLATION; EMBRYO; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; KNOCKOUT GENE; MOUSE; NEUROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA INTERFERENCE; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; NEUROBLASTOMA; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL PHOSPHATES; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33750526854     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-04-0301     Document Type: Article

References (39)

1. Ali, I. U., Schriml, L. M., and Dean, M. (1999). Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J. Natl. Cancer Inst. 91, 1922-1932,
2. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
3. Cantley, L. C., and Neel, B. G. (1999). New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96, 4240-4245.
4. Dahia, P. L., et al. (1999). PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum. Mol. Genet. 8, 185-193.
5. Das, S., Dixon, J. E., and Cho, W. (2003). Membrane-binding and activation mechanism of PTEN. Proc. Natl. Acad. Sci. USA 100, 7491-7496.
6. +/- mice. Science 285, 2122-2125.
7. Di Cristofano, A., and Pandolfi, P. P. (2000). The multiple roles of PTEN in tumor suppression. Cell 100, 387-390.
8. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. (1998). Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355.
9. Fox, J. A., Ung, K., Tanlimco, S. G., and Jirik, F. R. (2002). Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J. Immunol. 169, 49-54.
10. Hartmann, C., Johnk, L., Kitange, G., Wu, Y., Ashworth, L. K., Jenkins, R. B., and Louis, D. N. (2002). Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res. 62, 4100-4108.
11. Kwabi-Addo, B., Giri, D., Schmidt, K., Podsypanina, K., Parsons, R., Greenberg, N., and Ittmann, M. (2001). Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc. Natl. Acad. Sci. USA 98, 11563-11568.
12. Lemmon, M. A., and Ferguson, K. M. (2000). Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350, 1-18.
13. Leslie, N. R., and Downes, C. P. (2004). PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382, 1-11.
14. Li, Z., et al. (2005). Regulation of PTEN by Rho small GTPases. Nat. Cell Biol. 7, 399-404.
15. Lu, Y., et al. (2003). Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylirnositol 3-kinase/AKT cascades. J. Biol. Chem. 278, 40057-40066.
16. Ma, L., Teruya-Feldstein, J., Behrendt, N., Chen, Z., Noda, T., Hino, O., Cordon-Cardo, C., and Pandolfi, P. P. (2005). Generic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev. 19, 1779-1786.
17. Maehama, T., and Dixon, J. E. (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378.
18. Manning, B. D., Logsdon, M. N., Lipovsky, A. I., Abbott, D., Kwiatkowski, D. J., and Cantley, L. C. (2005). Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19, 1773-1778.
19. Marsit, C. J., Zheng, S., Aldape, K., Hinds, P. W., Nelson, H. H., Wiencke, J. K., and Kelsey, K. T. (2005). PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum. Pathol. 36, 768-776.
20. Miller, S. J., Lou, D. Y., Seldin, D. C., Lane, W. S., and Neel, B. G. (2002). Direct identification of PTEN phosphorylation sites. FEBS Lett. 528, 145-153.
21. +/- mice: a novel model of myelodysplasia. Blood 15, 4503-4510.
22. Mora, J., Cheung, N. K., Chen, L., Qin, J., and Gerald, W. (2001). Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin. Cancer Res. 7, 1358-1361.
23. Moritake, H., Horii, Y., Kuroda, H., and Sugimoto, T. (2001). Analysis of PTEN/MMAC1 alteration in neuroblastoma. Cancer Genet. Cytogenet. 125, 151-155.
24. Munoz, J., Lazcoz, P., Inda, M. M., Nistal, M., Pestana, A., Encio, I. J., and Castresana, J. S. (2004). Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines. Int. J. Cancer 109, 673-679.
25. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., and Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA 95, 13513-13518.
26. Okahara, F., Ikawa, H., Kanaho, Y., and Maehama, T. (2004). Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J. Biol. Chem. 279, 45300-45303.
27. Okahara, F., Itoh, K., Ebihara, M., Kobayashi, M., Maruyama, H., Kanaho, Y., and Maehama, T. (2005). Production of research-grade antibody by in vivo electroporation of DNA-encoding target protein. Anal. Biochem. 336, 138-140.
28. Smith, J. S., et al. (2000a). Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J. Clin. Oncol. 18, 636-645.
29. Smith, J. S., et al. (2000b). A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 64, 44-50.
30. Sumitomo, M., Iwase, A., Zheng, R., Navarro, D., Kaminetzky, D., Shen, R., Georgescu, M. M., and Nanus, D. M. (2004). Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell 5, 67-78.
31. Sun, H., Lesche, R., Li, D. M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N., Mueller, B., Liu, X., and Wu, H. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 96, 6199-6204.
32. Valiente, M., Andres-Pons, A., Gomar, B., Torres, J., Gil, A., Tapparel, C., Antonarakis, S. E., and Pulido, R. (2005). Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J. Biol. Chem. 280, 28936-28943.
33. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., and Waterfield, M. D. (2001). Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535-602.
34. Vazquez, F., Grossman, S. R., Takahashi, Y., Rokas, M. V., Nakamura, N., and Sellers, W. R. (2001). Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276, 48627-48630.
35. Vazquez, F., Ramaswamy, S., Nakamura, N., and Sellers, W. R. (2000). Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell. Biol. 20, 5010-5018.
36. Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M. B., Yuan, X. J., Wood, J., Ross, C., Sawyers, C. L., and Whang, Y. E. (2000a). Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc. Natl. Acad. Sci. USA 97, 4233-4238.
37. Wu, Y., Dowbenko, D., Spencer, S., Laura, R., Lee, J., Gu, Q., and Lasky, L. A. (2000b). Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J. Biol. Chem. 275, 21477-21485.
38. Xiao, A., Wu, H., Pandolfi, P. P., Louis, D. N., and Van Dyke, T. (2002). Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1, 157-168.
39. Yu, J. Y., DeRuiter, S. L., and Turner, D. L. (2002). RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 6047-6052.